HHS To Test Three New Models to Lower Drug Prices
Expanding on President Biden’s Executive Order, “Lowering Prescription Drug Costs for Americans,” the Department of Health and Human Services (HHS) announced a plan to test three new models to lower drug costs in the U.S. The models include $2 generic drugs, better access to cell and gene therapies, and developing new payment models for drugs granted accelerated approval.
It's free! Log in now to read
LATEST
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06